Old Well Partners, LLC Merus N.V. Transaction History

Old Well Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$23.58 - $30.91 $177,604 - $232,814	-7,532 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$20.0 - $32.29 $150,640 - $243,208	7,532 New	7,532 $240,000
Q2 2021 Aug 16, 2021	SELL	$20.0 - $25.48 $214,440 - $273,196	-10,722 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.14 - $29.11 $173,053 - $312,117	10,722 New	10,722 $224,000

200

61.9M

243K

300K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $1.92B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of Old Well Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Old Well Partners, LLC with notifications on news.